Literature DB >> 29654272

Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.

Phuong Cao Thi Ngoc1, Shi Hao Tan1, Tze King Tan1, Min Min Chan1, Zhenhua Li2, Allen E J Yeoh2,3, Daniel G Tenen1,4,5, Takaomi Sanda6,7.   

Abstract

TAL1/SCL is one of the most prevalent oncogenes in T-cell acute lymphoblastic leukemia (T-ALL). TAL1 and its regulatory partners (GATA3, RUNX1, and MYB) positively regulate each other and coordinately regulate the expression of their downstream target genes in T-ALL cells. However, long non-coding RNAs (lncRNAs) regulated by these factors are largely unknown. Here we established a bioinformatics pipeline and analyzed RNA-seq datasets with deep coverage to identify lncRNAs regulated by TAL1 in T-ALL cells. Our analysis predicted 57 putative lncRNAs that are activated by TAL1. Many of these transcripts were regulated by GATA3, RUNX1, and MYB in a coordinated manner. We identified two novel transcripts that were activated in multiple T-ALL cell samples but were downregulated in normal thymocytes. One transcript near the ARID5B gene locus was specifically expressed in TAL1-positive T-ALL cases. The other transcript located between the FAM49A and MYCN gene locus was also expressed in normal hematopoietic stem cells and T-cell progenitor cells. In addition, we identified a subset of lncRNAs that were negatively regulated by TAL1 and positively regulated by E-proteins in T-ALL cells. This included a known lncRNA (lnc-OAZ3-2:7) located near the RORC gene, which was expressed in normal thymocytes but repressed in TAL1-positive T-ALL cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29654272      PMCID: PMC8197659          DOI: 10.1038/s41375-018-0110-4

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  50 in total

1.  E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.

Authors:  G Bain; I Engel; E C Robanus Maandag; H P te Riele; J R Voland; L L Sharp; J Chun; B Huey; D Pinkel; C Murre
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

2.  Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Lee N Lawton; M Inmaculada Barrasa; Zi Peng Fan; Holger Kohlhammer; Alejandro Gutierrez; Wenxue Ma; Jessica Tatarek; Yebin Ahn; Michelle A Kelliher; Catriona H M Jamieson; Louis M Staudt; Richard A Young; A Thomas Look
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

Review 3.  Oncogenic transcription factors in the human acute leukemias.

Authors:  A T Look
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

4.  Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis.

Authors:  S Kurebayashi; E Ueda; M Sakaue; D D Patel; A Medvedev; F Zhang; A M Jetten
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 5.  SCL/TAL1: a multifaceted regulator from blood development to disease.

Authors:  Catherine Porcher; Hedia Chagraoui; Maiken S Kristiansen
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

6.  The NIH Roadmap Epigenomics Mapping Consortium.

Authors:  Bradley E Bernstein; John A Stamatoyannopoulos; Joseph F Costello; Bing Ren; Aleksandar Milosavljevic; Alexander Meissner; Manolis Kellis; Marco A Marra; Arthur L Beaudet; Joseph R Ecker; Peggy J Farnham; Martin Hirst; Eric S Lander; Tarjei S Mikkelsen; James A Thomson
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

7.  An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.

Authors:  Birgit Knoechel; Justine E Roderick; Kaylyn E Williamson; Jiang Zhu; Jens G Lohr; Matthew J Cotton; Shawn M Gillespie; Daniel Fernandez; Manching Ku; Hongfang Wang; Federica Piccioni; Serena J Silver; Mohit Jain; Daniel Pearson; Michael J Kluk; Christopher J Ott; Leonard D Shultz; Michael A Brehm; Dale L Greiner; Alejandro Gutierrez; Kimberly Stegmaier; Andrew L Kung; David E Root; James E Bradner; Jon C Aster; Michelle A Kelliher; Bradley E Bernstein
Journal:  Nat Genet       Date:  2014-03-02       Impact factor: 38.330

8.  TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.

Authors:  Jennifer O'Neil; Jennifer Shank; Nicole Cusson; Cornelis Murre; Michelle Kelliher
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

Review 9.  Long non-coding RNAs: new players in cell differentiation and development.

Authors:  Alessandro Fatica; Irene Bozzoni
Journal:  Nat Rev Genet       Date:  2013-12-03       Impact factor: 53.242

10.  Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.

Authors:  W S Liau; S H Tan; P C T Ngoc; C Q Wang; V Tergaonkar; H Feng; Z Gong; M Osato; A T Look; T Sanda
Journal:  Leukemia       Date:  2016-12-28       Impact factor: 11.528

View more
  16 in total

1.  Finding ARIEL under the sea of T-ALL circuits.

Authors:  Mark Y Chiang
Journal:  Blood       Date:  2019-07-18       Impact factor: 22.113

2.  A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.

Authors:  Karen Verboom; Wouter Van Loocke; Pieter-Jan Volders; Bieke Decaesteker; Francisco Avila Cobos; Simon Bornschein; Charles E de Bock; Zeynep Kalender Atak; Emmanuelle Clappier; Stein Aerts; Jan Cools; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Jo Vandesompele; Frank Speleman; Kaat Durinck
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

Review 3.  Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia.

Authors:  Homayon Yousefi; Daryush Purrahman; Mohammad Jamshidi; Elena Lak; Bijan Keikhaei; Mohammad-Reza Mahmoudian-Sani
Journal:  Clin Transl Oncol       Date:  2022-07-19       Impact factor: 3.340

Review 4.  The role of LncRNA MCM3AP-AS1 in human cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Mohadeseh Sheykhi-Sabzehpoush; Shahab Uddin; Mehri Ghafourian; Abdolah Mousavi Salehi; Mona Keivan; Maryam Cheraghzadeh; Zahra Nazeri; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-08-24       Impact factor: 3.340

5.  Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis.

Authors:  Chao Guo; Ming Gong; Zhenling Li
Journal:  Cancer Manag Res       Date:  2020-07-16       Impact factor: 3.989

6.  Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).

Authors:  Masahiro Kizaki
Journal:  Int J Hematol       Date:  2018-10-23       Impact factor: 2.490

Review 7.  lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response.

Authors:  Leah M Plasek; Saba Valadkhan
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-09       Impact factor: 4.249

Review 8.  Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects.

Authors:  Lilin Wan; Wenchao Li; Yuan Meng; Yue Hou; Ming Chen; Bin Xu
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

9.  A critical regulator of Bcl2 revealed by systematic transcript discovery of lncRNAs associated with T-cell differentiation.

Authors:  Wiam Saadi; Yasmina Kermezli; Lan T M Dao; Evelyne Mathieu; David Santiago-Algarra; Iris Manosalva; Magali Torres; Mohamed Belhocine; Lydie Pradel; Beatrice Loriod; Mourad Aribi; Denis Puthier; Salvatore Spicuglia
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

10.  LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL.

Authors:  Xuanmei Huang; Libin Huang; Qing Xie; Ling Zhang; Shaohui Huang; Mingye Hong; Jiangbin Li; Zunnan Huang; Hua Zhang
Journal:  Biomark Res       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.